Visioneering Technologies (ASX:VTI), a medical device company focused on developing advanced products that improve vision, has announced that Medilens Nordic AB has been named an authorised distributor for the NaturalVue (etafilcon A) Brand 1 Day Contact Lenses.
VTI said Medilens Nordic AB, headquartered in Sweden, is one of the leading ophthalmology-focused medical device companies in the Nordic region. It has become VTI's first European distributor.
Medilens Nordic AB operates in Sweden, Norway, Denmark, Finland and Iceland, providing a large suite of products to eye care professionals (ECPs).
VTI said a Medilens Nordic AB employs a highly trained sales force that includes opticians, pharmacists, and other technically trained specialists that call on over 1,400 ECPs.
“Medilens Nordic strives to maintain leadership in our field by providing our customers with the very best products, expertise, services and value,” said managing director Kent Maack.
“We believe that Visioneering’s revolutionary NaturalVue 1 Day Contact Lenses are taking us to the leading edge of vision technology. We’re thrilled to be the first distributor to introduce these new contact lenses in not only the Nordic region, but also the first in all of Europe.”
“Medilens Nordic is an ideal partner for Visioneering not only for their stellar reputation, but also because they work closely with eye care professionals in both public and private healthcare,” said Tony Sommer, senior vice president of Sales and Marketing for VTI.
“Maintaining close relationships with eye care professionals is our sweet spot. It’s core to our marketing philosophy, just as it is to Medilens Nordic’s. We’re looking forward to a long and productive relationship with them.”
